Revista Cubana de Angiología y Cirugía Vascular
Efectividad del Heberprot‑P® en el tratamiento del pie diabético isquémico
Par Carlos Noel Torres Tamayo, Pedro Alberto Perdomo García, Lizaidy Conte Castro et 3 autres.
Contenu en anglais
Résumé
Introduction
Diabetic foot is one of the most serious complications of diabetes mellitus, as it is the leading cause of non-traumatic lower limb amputation. Heberprot-P® is a recombinant human epidermal growth factor used to promote the healing of diabetic foot ulcers.
Objective
To evaluate the effectiveness of Heberprot-P® in the treatment of ischemic diabetic foot in patients at the Specialty Polyclinic of the “Dr. Antonio Luaces Iraola” Provincial General Teaching Hospital in Ciego de Ávila.